The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ISHL12 2022 | The role of CD4+ T-cells in the pathogenesis of Hodgkin lymphoma
In this video, Arjan Diepstra, PhD, University of Groningen, Groningen, The Netherlands, briefly comments on the role of CD4+ T-cells in the pathogenesis of Hodgkin lymphoma (HL), highlighting their importance in promoting the growth of tumor cells. This interview took place at the 12th International Symposium on Hodgkin Lymphoma (ISHL12), held in Cologne, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
